• Exchange: NASDAQ CM
  • Sector: Health Care
  • Industry: Biotech & Pharma
  • Sub-Industry: Biotech

ADXS:US

2.8800 USD 0.0200 0.70%

As of 20:10:00 ET on 07/29/2014.

Snapshot for Advaxis Inc (ADXS)

Open: 2.9600 Day's Range: 2.8400 - 2.9900 Volume: 82,841
Previous Close: 2.8600 52wk Range: 2.4600 - 11.7000 1-Yr Rtn: -12.73%

Stock Chart for ADXS

No chart data available.
  • ADXS:US 2.8800
  • 1D
  • 1M
  • 1Y
2.8600
Interactive ADXS Chart

Previous Close

No chart data available.
Interactive Chart
  • 1D
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Close:
Open:
High:
Low:
Volume:
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Key Statistics for ADXS

Current P/E Ratio (ttm) -
Estimated P/E(10/2014) -
Relative P/E vs. SPX -
Earnings Per Share (USD) (ttm) -1.2200
Est. EPS (USD) (10/2014) -1.1600
Est. PEG Ratio -
Market Cap (M USD) 55.51
Shares Outstanding (M) 19.27
30 Day Average Volume 103,226
Price/Book (mrq) 2.0006
Price/Sale (ttm) 45.3584
Dividend Indicated Gross Yield -%
Cash Dividend -
Dividend Ex-Date
5 Year Dividend Growth -
Next Earnings Announcement 09/16/2014
mrq = Most Recent Quarter; ttm = Trailing Twelve Months

Income Statement for ADXS

  • Revenue
  • Net Income (M/USD)
  • Profit Margin (%)

Company Profile & Key Executives for ADXS

Advaxis Inc., is a biotechnology company. The Company develops therapeutic cancer vaccines targeting cervical, head & neck, breast, prostate, and other cancers.

Daniel J O'ConnorPresident/CEOGregory T Mayes "Greg"Exec VP/COO
Robert PetitExec VP/Chief Scientific OfcrSara BonsteinSenior VP/CFO
More Company Profile & Key Executives for ADXS

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Sponsored Link
Advertisement
Advertisement
Sponsored Links
Advertisements
sec ||= nil